Europe Market Report for Minimally Invasive Sacroiliac Joint Fusion 2017 – MedCore

Europe Market Report for Minimally Invasive Sacroiliac Joint Fusion 2017 – MedCore

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 7/1/2017
  • Pages: 391
  • Type: MedCore

Studies have shown that over 80% of the population will suffer from lower back pain at some point in their lives. A majority of these cases can be attributed to two main causes: general factors, such as muscle strain, injury and overuse; and specific spine conditions such as herniated discs, degenerative disc disease (DDD), spondylolisthesis or spinal stenosis. Sacroiliac (SI) joint dysfunction was once thought to be a less common cause for lower back pain. However, recent studies have shown that SI joint dysfunction (SIJD) may be responsible for up to 30% to 35% of lower back pain.

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
The SI joint is a joint in the pelvis between the sacrum and ilium that is held together by strong ligaments. The SI joint is a strong, weight-bearing synovial joint with unique elevations that form an interlocking interface. Humans have two SI joints, one on either side of the sacrum. A primary function of the SI joint is shock absorption for the spine, as well as torque conversion, allowing transverse rotations in the lower extremities to be transferred up the spine.
SIJD can also be known as SI joint syndrome, SI joint strain and SI joint inflammation. Each term refers to a condition of the SI joint that causes pain from a variety of causes. Two common causes of SIJD include degenerative arthritis (osteoarthritis) and, in women, pregnancy. When this occurs, the most likely symptom is pain in the lower back or in the pelvic area. However, patients with SIJD often complain of pain in the lower limbs, which may be mistakenly diagnosed as sciatica.
Growth of this spinal treatment has historically been limited by the diagnosis process. There is significant controversy and uncertainty behind the diagnosis of SIJD. SIJD is a clinical diagnosis, where much of it is reliant on the feedback a patient provides their surgeon or pain doctor. As a result, most surgeons have been reluctant to diagnose SIJD as a source of their patient’s pain. The most accurate form of diagnosis is to perform an injection into the SI joint to numb the irritated area and thereby identify the pain source. The injected anesthetic can relieve the inflammatory pain that is common with SIJD. While the duration of this pain relief is often short-lived, it is an excellent tool for determining the SI joint as the source of pain.



The "Europe Market Report Suite for Minimally Invasive Spinal Implants 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Medtronic
DePuy Synthes
Orthofix
Zimmer Biomet
Stryker
Merit Medical
Globus Medical
Spinal Kinetic
DJO
NuVasive
Paradigm Spine
Ulrich Medical
Aesculap Inc.
Alphatec Spine
Optimed
K2M
Cook Medical
Others include: Aesculap Inc, Amedica, Amendia, Atlas Spine, Aurora Spine, Camber Spine, Captiva Spine, Centinel Spine, Clariance, CoreLink Surgical, Genesys Spine, GS Medical, Medacta International, Nexxt Spine, Orthocision, Orthofix, OsteoMed, Pinnacle Spine Group, RTI Surgical, Spineart, SpineFrontier, Spineology, Titan Spine, TranS1, VGI Medical, Xtant Medical, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×